Should CYP2C19 Genotyping Be Recommended as a Straight Forward Approach to Optimize Clopidogrel Utilization in Patients with Ischemic Stroke Complicated by Type 2 Diabetes Mellitus?

BACKGROUND: There have been few studies on CYP2C19 genotypes and clopidogrel response associated with ischemic stroke (IS), especially IS complicated by type 2 diabetes mellitus (T2DM). This study aimed to investigate the possible association between CYP2C19 polymorphisms and high on-treatment plate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jialin, Leng, Ping, Sun, Chen, Xu, Wen, Zhao, Zhenhuan, Li, Xiao, Zhang, Xiaolei, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698285/
https://www.ncbi.nlm.nih.gov/pubmed/33262635
http://dx.doi.org/10.2147/PGPM.S279719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698285/
https://www.ncbi.nlm.nih.gov/pubmed/33262635
http://dx.doi.org/10.2147/PGPM.S279719

Ejemplares similares